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Eps15-homology domain containing protein 2 (EHD2) is a
dynamin-related ATPase located at the neck of caveolae, but its
physiological function has remained unclear. Here, we found that
global genetic ablation of EHD2 in mice leads to increased lipid
droplet size in fat tissue. This organismic phenotype was paralleled
at the cellular level by increased fatty acid uptake via a caveolae-
and CD36-dependent pathway that also involves dynamin. Con-
comitantly, elevated numbers of detached caveolae were found
in brown and white adipose tissue lacking EHD2, and increased
caveolar mobility in mouse embryonic fibroblasts. EHD2 expression
itself was down-regulated in the visceral fat of two obese mouse
models and obese patients. Our data suggest that EHD2 controls a
cell-autonomous, caveolae-dependent fatty acid uptake pathway
and imply that low EHD2 expression levels are linked to obesity.
EHD2 ATPase | caveolae | fatty acid uptake | lipid metabolism | obesity
Caveolae are small membrane invaginations of the plasmamembrane that are abundantly found in adipocytes and en-
dothelial and muscle cells (1). They have been implicated in the
regulation of membrane tension (2, 3), in mediating lipid me-
tabolism (4), or in acting as distinct sites for specific and highly
regulated signaling cascades, such as the endothelial nitric oxide
synthase (eNOS)–nitric oxide (NO) pathway (5). The char-
acteristically shaped caveolar bulb has a typical diameter of 50 to
100 nm and is connected to the cell surface via a narrow neck
region. The integral membrane protein Caveolin (with three
isoforms in human, Cav1 to -3) and the peripheral membrane
protein Cavin (with four isoforms in human, Cavin1 to -4) build a
mesh-like coat around the caveolar bulb (6–10). In addition, Bin/
amphiphysin/Rvs domain-containing proteins of the PACSIN/
syndapin family (PACSIN1 to -3 in human) participate in the
biogenesis of caveolae (11–13).
Loss of Cav1/Cav3 or Cavin1 results in a complete lack of
caveolae from the plasma membrane (4, 14, 15). Cav1 knockout
(KO) mice suffer from cardiomyopathy, pulmonary hyperten-
sion, endothelium-dependent relaxation problems, and defective
lipid metabolism (1). In agreement with the latter, Cav1 KO mice
are resistant to high fat diet-induced obesity (16) and display smaller
white adipocytes and fat pads (17). Furthermore, increased levels of
triglycerides and fatty acids (FAs) are found in blood plasma sam-
ples obtained from Cav1 KO mice, suggesting a reduced cellular
uptake of FAs (16). A similar metabolic phenotype was found in
mice lacking Cavin1 (4, 18). Conversely, overexpression of Cav1 in
adipocytes results in an increased number of caveolae, enhanced fat
accumulation, enlarged adipocytes, and lipid droplets (LDs) (19).
These results suggest that caveolae are involved in lipid accumulation
in adipocytes and may promote FA uptake (20). However, the mo-
lecular mechanisms of caveolae-dependent fat uptake have remained
obscure.
Eps15 homology domain containing protein 2 (EHD2) local-
izes to the caveolar neck region (6, 21, 22). The protein belongs
to the dynamin-related EHD ATPase family, which comprises
four members in human (EHD1 to -4), and shows strong ex-
pression in human adipose and muscle tissue (human protein
atlas) (23). EHD2 is built of an N-terminal GTPase (G)-domain,
which mediates dimerization and oligomerization, a helical do-
main containing the membrane binding site, and a C-terminal
regulatory Eps15 homology (EH)-domain. The proteins exist in a
closed auto-inhibited conformation in solution (24). When
recruited to membranes, a series of conformational changes
align the phospholipid binding sites with the membrane and
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facilitate oligomerization of EHD2 into ring-like structures
(25–27).
Down-regulation of EHD2 in cell culture results in decreased
surface association and increased mobility of caveolae whereas
EHD2 overexpression stabilizes caveolae at the plasma mem-
brane (9, 21, 22, 28). This led to the hypothesis that formation of
an EHD2-ring at the neck of caveolae restricts caveolar mobility
within the membrane. In agreement with this hypothesis, EHD2
assembles in an ATP-dependent fashion into ring-like oligomers
in vitro and induces the formation of tubular liposomes with an
inner diameter of 20 nm, corresponding to the diameter of the
caveolar neck (24). Whether EHD2 also controls caveolar
membrane dynamics in vivo and what the physiological conse-
quences of EHD2 loss at the organismic level are is unknown.
In this study, we found that EHD2 KOmice display enlarged LDs
in white and brown adipose tissue (WAT/BAT) and in caveolae-
containing cell types, like adipocytes or fibroblasts, although total
cellular triglyceride levels were not altered. In adipose tissue lacking
EHD2, caveolae were frequently detached from the plasma mem-
brane and displayed elevated mobility. Furthermore, in two obesity
mouse models, as well as in white adipose tissue (WAT) of obese
patients, reduced EHD2 expression and an increased number of
detached caveolae were found in visceral fat. Our data establish
EHD2 as a negative regulator of caveolae-dependent lipid uptake
and implicate a role of caveolar stability and dynamics for lipid
homeostasis and obesity.
Results
Generation of EHD2 Knockout Mice. To examine the physiological
function of EHD2, a mouse strain with LoxP recognition sites
surrounding exon 3 and intron 3 of the Ehd2 gene was engi-
neered (Fig. 1A). Exon 3 encodes residues 137 to 167 of the
highly conserved GTPase domain, and its deletion is predicted to
result in nonfunctional protein. Following global removal of
exon 3 by crossings with a germ line-specific Cre-deleter strain,
offspring mice were back-crossed with the C57BL6/N mouse
strain for five generations, yielding a global EHD2 KO mouse
model. Genotyping of offspring confirmed the successful dele-
tion (del) of EHD2 exon 3 in EHD2 del/del animals (SI Ap-
pendix, Fig. S1A), and real-time PCR revealed the absence of
EHD2 messenger RNA (mRNA) in the EHD2 del/del tissue
(Fig. 1B). Western blot analysis indicated the complete loss of
EHD2 in WAT and various other tissues of EHD2 del/del mice
compared to abundant EHD2 expression in EHD2 +/+ and del/+
mice (Fig. 1C and SI Appendix, Fig. S1 B–D). Cav1 and Cavin1
protein levels remained grossly unaltered upon loss of EHD2
(Fig. 1C and SI Appendix, Fig. S1D). Accordingly, immunostaining
of cryostat sections obtained from EHD2 del/del BAT did not
reveal apparent differences in Cav1 or Cavin1 expression and
localization (SI Appendix, Fig. S1E) whereas EHD2 staining was
completely abolished (Fig. 1D).
Loss of EHD2 Results in Increased Lipid Droplet Size. EHD2 del/del
mice were born in normal Mendelian ratios, were fertile, and did
not show an obvious phenotype upon initial inspection. In con-
trast to the reported loss of white fat mass in Cav1 and Cavin1
KO mouse models (4, 16, 17), 1-y-old EHD2 del/del male mice
were not apparently lipodystrophic and did not display any de-
tectable weight difference when compared to EHD2 del/+ mice
(Fig. 1E). However, several of the EHD2 del/del mice showed
increased deposits of epigonadal and peri-inguinal white fat (Fig.
1F). This suggested that loss of EHD2 led to a more subtle
phenotype, such as the dysregulation of lipid storage capacity.
When analyzed at the cellular level, white adipocytes of EHD2
del/del mice showed an increased cell size compared to adipo-
cytes from EHD2 del/+ mice or adult C57BL6/N mice (Fig. 1G
and SI Appendix, Fig. S2A). In contrast to EHD2 del/+ BAT with its
distinct brown appearance, EHD2 del/del BAT showed increased
beige and white coloring (Fig. 1H). Histological inspections of BAT
paraffin and cryostat sections stained against the LD coat protein
Perilipin1 indicated an increased LD size in EHD2 del/del BAT
compared to EHD2 del/+ or C57BL6/N mice (Fig. 1H and SI
Appendix, Fig. S2 B and C). Concurrently, the number of LDs in
brown adipocytes was reduced in cells lacking EHD2 (Fig. 1I).
Despite their enlarged sizes, we did not observe an abnormal LD
shape in brown adipocytes from EHD2 del/del mice compared to
EHD2 del/+ by electron microscopy (EM) and light microscopy
analysis (SI Appendix, Fig. S3). Thus, LDs in EHD2 del/del brown
adipocytes showed an apparently normal shape and protein coat
and regular contact sites with mitochondria (SI Appendix, Fig. S3
A–D). Based on mass spectrometry analysis (29), it was previously
proposed that EHD2 is partially associated with LDs. However,
immunostainings of mouse embryonic fibroblasts (MEFs) revealed
EHD2 rarely at LDs, as reflected by Pearson correlation analysis (SI
Appendix, Fig. S3 E and F). As no significant differences in lipid
accumulation were found in EHD2 del/+ and C57BL6/N male mice
(SI Appendix, Fig. S2) and to reduce animal numbers, the following
experiments were carried out with EHD2 del/+ as control group to
EHD2 del/del male mice.
Based on the increased LD sizes in EHD2-lacking adipocyte
tissue, we further investigated if the lipid content and adipocyte
differentiation was altered in EHD2 del/del WAT and BAT.
However, similar diacyl- and triacylglyceride concentrations were
found in EHD2 del/+ and del/del WAT and BAT (Fig. 1 J and K
and SI Appendix, Fig. S2D), in agreement with the similar weight
of EHD2 del/del and del/+ mice. Total cholesterol and choles-
terol esters were slightly increased in EHD2 del/del BAT, but
not in WAT (Fig. 1 L and M). In addition, we did not detect any
significant differences in adiponectin, leptin, and insulin plasma
levels in EHD2 del/del compared to del/+ mice (SI Appendix,
Fig. S4). Free FA concentrations in blood plasma were slightly
reduced in EHD2 del/del, in line with a possible increase in
cellular FA uptake (SI Appendix, Fig. S4). Adipogenic marker
genes like PPARγ, Retn, or Serpina3k displayed a slightly in-
creased expression in EHD2 del/del WAT or differentiated
primary adipocytes compared to EHD2 del/+ (SI Appendix, Fig.
S5A), indicating that differentiation was not altered. Contrarily,
we observed a decreased expression of genes involved in de novo
lipogenesis in isolated WAT obtained from EHD2 del/del vs.
EHD2 del/+ mice or in primary adipocyte cell cultures (SI Ap-
pendix, Fig. S5B), suggesting that down-regulation of lipogenesis
is an active mechanism that partially compensates for the in-
creased lipid accumulation. However, EHD2 del/del WAT or
adipocytes showed increased expression of proteins involved in
LD biogenesis [e.g., DGAT2, Perilipin1, and Lipin1 (SI Appen-
dix, Fig. S5C)] and FA activation, such as Acyl-CoA Synthetase
Long Chain Family Member 3 and -4 (SI Appendix, Fig. S5D). In
summary, the absence of EHD2 leads to decreased expression
levels of genes involved in de novo fat metabolism and increased
expression levels of genes associated with the synthesis of LDs.
Increased Rates of Lipid Uptake in Adipocytes Lacking EHD2. To
characterize the mechanism of increased LDs in EHD2 del/del
fat cells, lipid metabolism was investigated in cultured adipo-
cytes. Primary preadipocytes were isolated from WAT of EHD2
del/+ and EHD2 del/del mice and differentiated into mature
adipocytes, followed by boron dipyrromethene (BODIPY)
staining to label LDs. Undifferentiated EHD2 del/del pre-
adipocytes showed increased LD size compared to EHD2 del/+
preadipocytes, a difference that was even more pronounced in
differentiated adipocytes (Fig. 2 A and B). Three-dimensional
(3D) reconstructions of EHD2 del/del differentiated adipocytes
illustrated an extensively increased volume of some LDs in del/del
differentiated adipocytes (Fig. 2C).
We addressed the possibility that increased lipid uptake is a
secondary effect of EHD2 deletion mediated via putative organ
7472 | www.pnas.org/cgi/doi/10.1073/pnas.1918415117 Matthaeus et al.
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cross-talk. We therefore repeated the experiments with cultured
adipocytes derived from EHD2 conditional knockout (cKO) flox/flox
mice, in which EHD2 expression was down-regulated by expression
of Cre recombinase via viral transfection. Again, EHD2 removal led
to increased LD growth (SI Appendix, Fig. S6 A and B), indicating a
cell-autonomous function of EHD2 in controlling lipid uptake.
A previous study suggested that EHD2 knock-down leads to
impaired adipogenic differentiation in 3T3-L1 cells, and, as a
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Fig. 1. Loss of EHD2 results in increased lipid accumulation in white and brown adipose tissue. (A) Generation of the EHD2 KO mouse model. A targeting
vector containing a pGK-Neomycin (neo) cassette and loxP sites flanking exon 3 was placed in the EHD2 wild-type allele. EHD2 del/del mice were obtained by
breeding with Cre-deleter mouse strain (diphtheria toxin A [DTA]). (B) EHD2 mRNA level in EHD2 del/+ and EHD2 del/del mice (mRNA from BAT, n = 5). (C)
Western blot analysis of WAT of EHD2 +/+, +/−, and −/− mice against EHD2, Cav1, and Cavin1. (D) EHD2 immunostaining in BAT cryostat sections from EHD2 +/+,
del/+, and del/del mice. (E) The body weight was monitored over 12 mo (n = 7). (F) EHD2 del/+ and EHD2 del/del mice during preparation. (G) Masson trichrome
staining of WAT paraffin sections of EHD2 del/+ and EHD2 del/del. Analysis of the adipocyte cell size [n(del/+) = 172/3, n(del/del) = 199/3]. (H) EHD2 del/del mice
showed increased amount of beige BAT in the neck region. In addition, white adipocytes were infiltrated into the BAT depots (white arrowheads). (Left) Masson
trichrome staining of EHD2 del/+ and del/del BAT paraffin sections. (Right) BAT cryostat sections were stained against the LD coat protein Perilipin1 to visualize
LDs. (I) LD size, number per cell, and cell area were measured in BAT cryostat sections [n(del/+) = 118/3, n(del/del) = 104/3]. (J–M) Triglyceride (TG; J and K), total
cholesterol, and cholesterol ester (L andM) concentrations were determined for WAT (n = 5 to 8) and BAT (n = 5 to 6) of EHD2 del/+ and del/del mice. Line graph
represents mean ± SE, column bar graphs show mean + SE or each replicate with mean ± SE, normal distributed groups were analyzed by t test, not normally
distributed values with Mann–Whitney U test, *P < 0.05, ***P < 0.0001. For comparison to C57BL6/N, see also SI Appendix, Figs. S1 and S2.
Matthaeus et al. PNAS | March 31, 2020 | vol. 117 | no. 13 | 7473
PH
YS
IO
LO
G
Y
D
ow
nl
oa
de
d 
at
 D
KF
Z-
HG
F 
on
 A
pr
il 1
4,
 2
02
0 
consequence, to smaller LDs (30). However, we reproduced our
observation of increased LD sizes induced by the loss of EHD2
also in 3T3-L1 cells, even if we followed the published differ-
entiation and EHD2 knockdown protocol (SI Appendix, Fig. S6
C–H). As already observed in EHD2-lacking BAT, the number
of LDs was reduced in EHD2-knockout adipocytes (Fig. 2D).
LD growth can be mediated by the uptake of extracellular FAs
and their conversion into triglycerides whereas glucose uptake and
de novo lipogenesis play minor roles in this process (31, 32). FAs
and lipids are present at high concentrations in fetal bovine serum
(FBS). Addition of delipidated FBS during adipocyte differenti-
ation resulted in complete loss of LDs in both genotypes (SI Ap-
pendix, Fig. S6 I and J) whereas glucose depletion led to a general
impairment of adipocyte differentiation. Importantly, enlarged
LDs were still observed in KO adipocytes, even under conditions
of glucose depletion (SI Appendix, Fig. S6 I and J). These data led
us to hypothesize that the increased LD size in EHD2 del/del
adipocytes may be a consequence of increased FA uptake, in line
with the suggested function of caveolae in FA uptake (33–35).
To test this possibility directly, we monitored the uptake of extra-
cellularly added FAs into differentiated adipocytes using BODIPY-
labeled dodecanoic acid (FA12) paired with fluorescence-activated
cell sorting (FACS) analysis. After 5 min, only a minor fraction of
EHD2 del/+ adipocytes displayed intense BODIPY staining
(R2; for definition, see Fig. 2E). This R2 population in-
creased to more than 30% after 60 min of BODIPY-FA12
treatment (Fig. 2 E and F and SI Appendix, Fig. S6 K and
L). EHD2 del/del adipocytes displayed increased BODIPY
staining at both early and late time points, indicating
accelerated FA uptake (Fig. 2 E and F and SI Appendix, Fig.
S6 K and L). This conclusion was further supported by light
microscopy imaging, which revealed more intense BODIPY
staining of EHD2 del/del compared to EHD2 del/+ adipo-
cytes after 60 min of FA incubation (SI Appendix, Fig. S6M).
In contrast, EHD2 del/+ and EHD2 del/del adipocytes did
not differ with respect to their ability to take up extracellu-
larly added glucose (SI Appendix, Fig. S6 N–P). Previously, an
involvement of EHD2 in the autophagic engulfment of LDs
(lipophagy) was suggested (36). However, inducing starvation
by incubation of differentiated adipocytes with Hanks’ bal-
anced salt solution (HBSS) revealed no differences in the
release of stored lipids in EHD2 del/+ and EHD2 del/del
adipocytes, and both genotypes displayed similar reductions
in lipid accumulation (SI Appendix, Fig. S6Q). These data
indicate that loss of EHD2 does not affect the release of FAs
or lipophagy but specifically controls LD size by regulating
FA uptake.
Loss of EHD2 Results in Detachment of Caveolae from the Plasma
Membrane In Vivo. Given the described role of caveolae in the
uptake of FAs (16), we hypothesized that EHD2 may restrict FA
uptake by controlling caveolar function. To test whether loss of
EHD2 affects caveolar morphology, WAT and BAT were ana-
lyzed by electron microscopy (EM). Caveolae in EHD2 del/+
BAT were mostly membrane-bound and displayed the charac-
teristic flask-shaped morphology (Fig. 3A, white arrowheads,
ratio detached/membrane bound caveolae = 0.27). Strikingly, an
increased number of caveolae appeared detached from the
plasma membrane in BAT isolated from EHD2 del/del mice
compared to EHD2 del/+ controls, as judged from the complete
closure of the lipid bilayer in the plasma membrane and the
caveolae (Fig. 3 A, white arrowheads, and B, ratio detached/
membrane bound caveolae = 1.75). The total number of cav-
eolae, as well as the caveolar diameter and size, was unchanged
in brown adipocytes lacking EHD2.
An increased number of detached caveolae were also observed
in EHD2 del/del white adipocytes compared to EHD2 del/+ cells
from littermate controls (Fig. 3 C, black and white arrowheads,
and D, ratio detached/membrane bound caveolae [del/del] = 1.2
vs. ratio [del/+] = 0.24). In white adipocytes, the total number of
caveolae was reduced while both caveolar size and diameter were
increased in EHD2 del/del compared to EHD2 del/+ animals
(Fig. 3D). Cav1 immunogold labeling confirmed that the round
vesicles close to the plasma membrane, indeed, were detached
caveolae (Fig. 3E). The 3D visualization of EHD2 del/del brown
adipocyte by electron tomography (ET) further indicated that the
majority of detached caveolae in two-dimensional EM images
were not connected to the plasma membrane (Fig. 3 F and G and
Movie S1) but localized 20 to 30 nm underneath (Fig. 3 G, a–c)
although some caveolae close to the plasma membrane showed
thin connections (Fig. 3 G, b and d, white arrowhead). Taken
together, EM and ET reveal an increased detachment of caveolae
from the plasma membrane in EHD2 del/del adipocytes, sug-
gesting a crucial function for EHD2 in the stabilization of
caveolae at the plasma membrane.
Increased Caveolar Mobility in EHD2 Knockout Cells. To further dis-
sect the interplay of caveolar mobility and LD growth at the molec-
ular level, we investigated caveolar mobility and endocytosis in mouse
embryonic fibroblasts (MEFs) by total internal reflection fluorescence
(TIRF) microscopy. MEFs derived from EHD2 +/+ and del/del mice
were transfected with a plasmid expressing Cav1 fused to enhanced
green fluorescence protein (pCav1-EGFP) to label single caveolae.
As illustrated in Fig. 4A, regions of moderate Cav1 expression were
investigated to ensure that distinct Cav1 spots were observed during
the analysis. Live TIRF imaging of EHD2 +/+MEFs showed a slow
or no continuous movement for the majority of investigated caveolae
(Movie S2). However, single caveolae moved along the plasma
membrane or left the TIRF illumination zone toward the inside of
the cell, indicating their spontaneous detachment, as previously
reported (21). Strikingly, movement and velocity of caveolae were
greatly increased in EHD2 del/del MEFs (Movie S3), not allowing
Cav1 single spots to be tracked. Line scan analysis revealed a greatly
reduced number of fixed, nonmoving Cav1 spots (referred to as lines
in Fig. 4B) in EHD2 del/del MEFs compared to EHD2 +/+ cells.
Moreover, a larger number of highly mobile Cav1 sparks, reflecting
fast moving caveolae, were found in EHD2 del/del cells (Fig. 4 A and
B). Reexpression of EHD2 in EHD2 del/del MEFs reduced the
mobility of caveolae, often leading to their immobilization (SI Ap-
pendix, Fig. S7 A and B and Movie S4).
Determinants of EHD2-Mediated Fatty Acid Uptake. We further
characterized the determinants of FA uptake in MEFs. Similar
to EHD2 del/del adipocytes, EHD2 del/del MEFs showed in-
creased lipid accumulation and LD size after adipogenic differ-
entiation or 6 h oleic acid treatment, as illustrated by LD
BODIPY staining (SI Appendix, Fig. S8 A and B). Furthermore,
the total number of LDs was reduced in EHD2 del/del MEFs after
6 h oleic acid treatment although the cell size was not altered (SI
Appendix, Fig. S8 C and D). Compared to EHD2 +/+ MEFs,
cholesterol and cholesterol ester concentrations were slightly in-
creased in MEFs lacking EHD2 (SI Appendix, Fig. S8E), as al-
ready observed in EHD2 del/del BAT. Triglyceride levels were
marginally reduced in EHD2 del/del MEFs (SI Appendix, Fig.
S8F), probably due to the lower number of LDs found in EHD2
del/del cells. Notably, free fatty acid levels were similar in un-
treated EHD2 +/+ and del/del cells (SI Appendix, Fig. S8G).
However, short-term (1 h) and, even more pronounced, long-term
(24 h) exposure to oleic acid led to increased free fatty acid
concentrations in EHD2 del/del cells (SI Appendix, Fig. S8G).
Reexpression of an EGFP-tagged EHD2 version in EHD2 +/+
and del/del MEFs rescued the observed LD phenotype, even
reducing the size of LDs compared to EGFP expressing cells
(Fig. 5 A and B). These data indicate a general and cell auton-
omous role of EHD2 in the control of LD growth and size that is
not restricted to fat cells.
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To identify the functional regions within EHD2 that are cru-
cial for regulating lipid uptake, we transfected EHD2 del/del
MEFs with various EGFP-tagged EHD2 deletion constructs.
EHD2 constructs lacking the N terminus, the EH-domain, or
both rescued EHD2 loss, resulting in smaller LDs (SI Appendix,
Fig. S8 H and I). In contrast, expression of single EHD2 mutants
affecting membrane binding (F322A) or oligomerization/ATPase
activity of EHD2 (F122A) did not reduce LD size, indicating a
crucial role of these properties for EHD2 function.
To analyze if the observed phenotype in EHD2 del/del
MEFs was dependent on caveolae, MEFs lacking EHD2 were
treated with Cav1 or Cavin1 small interfering RNA (siRNA)
(SI Appendix, Fig. S8 J and K) to eliminate caveolae. LD size
in EHD2 del/del MEFs was significantly decreased following
depletion of Cav1 or Cavin1 (Fig. 5C), indicating that the
effects of EHD2 on LD size require, and likely are mediated
by, caveolae.
It was previously reported that dynamin localizes to caveolae (37).
Indeed, dynamin was observed in close proximity to Cav1 in immu-
nostaining of MEFs, indicated by similar fluorescence intensity plot
profiles (SI Appendix, Fig. S7C). Consistent with a role of dynamin in
caveolae function, overexpression of a dynamin 2 dominant-negative
mutant (pGFP-Dyn2-K44A) completely abolished the fast caveolar
mobility in EHD2-lacking cells (SI Appendix, Fig. S7D–F andMovies
S5 and S6). Consequently, overexpression of the K44A mutant pre-
vented increased LD size in EHD2 del/del MEFs (Fig. 5 D and E),
pointing again to a link between caveolar mobility and FA uptake.
Previous work has implicated the FA binding membrane protein
CD36 in caveolae-dependent FA uptake (33, 38, 39). To test whether
CD36 is found in caveolae, we performed CD36 immunostaining of
unfixedMEFs to preserve membrane structures. Indeed, CD36 partly
colocalized with Cav1, indicating an accumulation of CD36 within
caveolae (SI Appendix, Fig. S9A). However, we also observed CD36
in noncaveolar plasma membrane domains. Interestingly, correct
CD36 plasma membrane localization depends on Cav1 expression as
knockdown of Cav1 by three independent siRNAs revealed a de-
crease in CD36 antibody staining (SI Appendix, Fig. S9 B–D).
To probe a possible function of CD36 in EHD2-dependent lipid
uptake, CD36 expression in MEFs was down-regulated by treat-
ment with either one of three specific CD36 siRNAs. Antibody
staining confirmed the efficient knockdown of CD36 in EHD2 +/+
and del/del MEFs (Fig. 5F). Removal of CD36 in EHD2 +/+ and
del/del MEFs dramatically decreased the size of LDs compared to
control siRNA-treated cells (Fig. 5 F and G). Hence, the observed
enlargement of LDs in cells lacking EHD2 depends on CD36.
These converging lines of evidence suggest that caveolae dynamics
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is key to the regulation of FA internalization and that this is coupled
to the previously shown roles of CD36 and caveolin.
Fatty Acid Trafficking Is Partially Mediated by Caveolae. The in-
creased LD growth in EHD2 del/del MEFs suggests an FA traf-
ficking route from the plasma membrane into the endoplasmic
reticulum (ER) and, subsequently, to LDs. To further characterize
this pathway, we followed the uptake of BODIPY-labeled FAs by
time-resolved microscopy. TIRF live imaging showed fast FA in-
tercalation into the plasma membrane of EHD2 +/+ and del/del
MEFs (Fig. 6A and Movies S7 and S8). Concomitant with FA
enrichment at the cell surface, we observed FA accumulation in
single caveolae (Fig. 6B). Time-resolved tracking analysis in-
dicated that FAs were also incorporated into mobile caveolae
(Fig. 6C and Movies S9 and S10).
Next, we investigated the intracellular FA trafficking by con-
focal microscopy in fixed MEFs to identify the involved organ-
elles. Within 1 min of FA treatment in EHD2 +/+ and del/del
MEFs, labeled FAs were found inside the cell (Fig. 6 D and E).
Both EHD2 +/+ and del/del MEFs showed FA trafficking into
the ER. Cav1 gene silencing did not alter initial FA accumula-
tion in the membrane and ER, suggesting that caveolae are not
involved in the fast FA uptake step. After 3 min, labeled FAs
were already found in LDs (see arrowheads in Fig. 6 D and E;
also, see SI Appendix, Fig. S10A). Within 5 to 10 min of treat-
ment, ER and LDs were intensively stained.
To analyze the caveolae dependence of this process, we quantified
internalized cellular FAs by fluorescence intensity measurements
(Fig. 6 F andG). Caveolae-dependent FA uptake was apparent after
10 min in EHD2 +/+ MEFs. Strikingly, in the absence of EHD2,
caveolae-dependent FA uptake was already observed after 3 min and
persisted to 10 min. Thus, cellular FA uptake follows an initial fast
uptake route that is not dependent on caveolae, and a slower,
caveolae-dependent uptake route that is modified by EHD2. Further
FA processing steps, such as incorporation of FAs in diacylglycerol
(DAG) followed by triacylglycerol conversion, were investigated by
thin-layer chromatography (TLC) and lipid-based mass spectromet-
ric (MS) analysis. Within 10 min of BODIPY-labeled FA (C12)
treatment, BODIPY-positive DAG species were detected by
TLC in EHD2 +/+ and del/del MEFs (SI Appendix, Fig. S10B). MS
analysis further verified BODIPY-FA-C12 incorporation into DAG
BODIPY-FA-C12/22:0 (corresponding to a mass to charge ratio
peak of 832.4 in SI Appendix, Fig. S10 C and D), indicating correct
intracellular processing of the internalized BODIPY-labeled FAs
for EHD2 +/+ and del/del MEFs. Up to 20 min, no BODIPY-
positive TAG species was detected, probably due to short in-
cubation time. However, these data further support our conclusion
that loss of EHD2 increases the FA uptake into cells, but not the
following FA processing steps.
Decreased EHD2 Expression in Genetic Obesity Models or in Diet-
Induced Obesity. Our data indicate an EHD2-dependent control
of lipid uptake in adipose tissue, suggesting that EHD2 expression
might be dysregulated in obese mice and humans. We therefore
investigated if EHD2 expression is altered in two obesity-related
mouse models, ob/ob and NZO (40). Indeed, WAT obtained from
ob/ob and NZO mice showed reduced EHD2 expression com-
pared to C57BL6/J mice fed by standard diet (Fig. 7A). When
investigating adipocytes from ob/ob mice, a higher proportion of
detached caveolae were found in the obesity mouse model (ratio
detached/membrane bound caveolae = 1.4 vs. 0.35 in C57BL6/N
mice fed with standard diet) (Fig. 7 B and C). In addition, we
analyzed EHD2 expression in visceral and subcutaneous WAT
from patients ranking in their body mass index (BMI) from normal
to morbid obesity (BMI < 25 to BMI > 40) (Fig. 7 D and E). In
both depots, EHD2 expression was highest in normal weight
subjects and was significantly lower in overweight and obese
people whereas EHD2 expression did not differ between different
obesity stages. These data imply that EHD2 expression is regu-
lated by lipid uptake and load and suggest that EHD2-mediated
caveolar dynamics may be altered in obesity.
Discussion
Here, we identify EHD2 as a negative regulator of caveolae-
dependent lipid uptake. Loss of EHD2 resulted in increased LDs
in adipose tissue of the whole organism, as well as in cell culture-
based experiments. Loss of EHD2 was associated with the de-
tachment of caveolae from the plasma membrane, higher caveolar
mobility, and increased FA uptake. We demonstrate that caveolae,
the fatty acid translocase CD36, and dynamin-2 play a critical role
in the EHD2-dependent lipid uptake pathway. In addition,
obese mice and humans exhibit decreased EHD2 expression in
WAT. Thus, our study reveals a cell-autonomous, caveolae-
dependent lipid uptake route that is controlled by EHD2 and
modified by metabolic conditions.
For some time, caveolae have been implicated in lipid uptake.
Thus, mice lacking caveolae showed reduced fat mass and did not
develop any form of obesity. In addition, Pohl et al. (41) observed
decreased oleate uptake after expression of a dominant-negative
Cav1 mutant. The EHD2 KO mouse model, described here,
revealed the opposite phenotype: e.g., a caveolae gain-of-function
in vivo model. In EHD2 KO mice, caveolae were more often de-
tached from the plasma membrane and showed a higher mobility
and faster lipid uptake, resulting in enlarged LDs. Unlike in Cav1
overexpressing mice (19), which also show increased FA uptake, the
number of caveolae was not increased in EHD2 KO mice. This
supports a model in which not only caveolae number, but also
caveolar dynamics play a crucial role in this process (Fig. 7F).
Furthermore, this idea is in line with our structural findings that
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Fig. 4. Enhanced caveolar mobility in cells lacking EHD2. (A and B) TIRF live-
imaging of EHD2 +/+ and del/del MEFs expressing pCav1-EGFP (in A, white
boxes indicate magnified cell areas in which regions of interest, illustrated in
yellow boxes, were analyzed). Line scan analysis of the recorded Cav1 in-
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caveolae single sparks (as illustrated in a and b). n(+/+) = 90/3; n(del/del) = 92/
3; each replicate is represented with mean ± SE, ***P < 0.0001. t, time; x,
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EHD2 can form ring-like oligomers that may stabilize the neck of
caveolae (24–27), thereby restricting caveolar mobility (21, 22).
Based on studies in the EHD2 KO NIH 3T3 cell line, Yeow et al.
(42) suggested that EHD1 and/or EHD4 can rescue the loss of
EHD2. However, we did not find rescue of caveolae detachment
and lipid uptake in EHD2 KO cells by other EHD family members.
The pathway of caveolae-dependent cellular lipid uptake
has been intensively studied (4, 19, 20, 33, 34), but the exact
molecular mechanisms are still unclear. Our observation indicates
that FA uptake depends on caveolar dynamics and detachment,
processes which are controlled by EHD2. Indeed, we observed
single mobile caveolae loaded with FAs, indicating that caveolae
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can shuttle FAs from the plasma membrane into the cell. In agree-
ment with previous results (43–45), our analysis of intracellular FA
trafficking in MEFs revealed an accumulation of fluorescently labeled
FAs in the ER and LDs within minutes. Interestingly, we observed an
initial, fast, caveolae-independent and a slower, caveolae-dependent
FA uptake. Only the latter was accelerated in the absence of EHD2. It
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remains elusive how caveolae precisely shuttle FAs to the ER
and/or LDs and whether adipose cells may adopt specialized
features in their lipid trafficking pathway compared to MEFs.
The EHD2 knockout mouse model will be a useful tool to fur-
ther dissect the molecular mechanisms of caveolae-dependent
lipid uptake in various tissues.
The loss of EHD2 on the cellular level led to increased fat
deposits on the organismic level, which was particularly evident in
older animals. The observed phenotype based on the global loss of
EHD2 could be influenced by organ cross-talk (46). However, we
did not find any evidence for differences in adipocyte-derived
secretory factors, such as leptin (SI Appendix, Fig. S4). Further-
more, increased lipid uptake was dependent on caveolae, as shown
by Cav1 and Cavin1 knockdown experiments, and LD growth
could specifically be induced by viral infection of Cre recombinase
in EHD2 cKO flox/flox, but not in flox/wild type adipocytes. Thus,
increased lipid uptake is caused by a cell-autonomous, caveolae-
dependent mechanism. Morén et al. (30) observed a decreased
LD size in differentiated 3T3-L1 cells that were treated with
EHD2 siRNA 4 d after initial differentiation. However, we ob-
served increased LD size when EHD2 was silenced as described in
Morén et al. (30) or during the entire differentiation process. The
cause of this apparent discrepancy is unclear, but, given the wealth
of data from various cell types and cell lines described in the
current study, we are convinced that EHD2 loss generally leads to
increased lipid droplet size.
Despite the increased LDs in mice lacking EHD2, the body
weight and triglyceride content of EHD2 del/del and EHD2 del/+
mice were similar. This suggests alterations in LD biogenesis, but
not in triglyceride storage itself in the absence of EHD2. Indeed,
FA processing steps appeared similar in EHD2 lacking MEFs (SI
Appendix, Fig. S10). In line with the latter and consistent with our
fatty acid uptake experiments, we observed increased cellular free
FA levels in the absence of EHD2, at least in the first 24 h upon
exposure to high fatty acid concentrations. Compared to triglycer-
ides, EHD2-lacking BAT and MEFs showed slightly increased
cholesterol and cholesterol ester concentrations. This is a particu-
larly interesting as caveolae are enriched in cholesterol, and the
increased uptake of caveolae in EHD2 del/del cells may therefore
concurrently lead to increased cholesterol uptake. In line with the
increased FA uptake rates and LD sizes, we observed up-regulation
of LD biogenesis genes, like Perilipin1 or DGAT2. Intracellular
FAs are known to activate the transcription factor PPARγ (47–49),
which, in addition, tended to be up-regulated in EHD2-lacking
tissue. Consequently, PPARγ may induce the transcription of vari-
ous adipogenic and LD-related genes, as observed in our expression
analyses.
EHD2 del/del WAT and cultivated EHD2 del/del adipocytes
showed reduced expression levels of genes involved in de novo
lipogenesis, like SREBP1 or FAS. Similar compensatory mech-
anisms were noted in patients suffering from obesity (50–52).
Remarkably, the expression levels of EHD2 were strongly re-
duced in WAT from obese patients, as well as in WAT of two
obese mouse models (ob/ob and NZO mice). Thus, expression of
EHD2 appears to negatively correlate with adipocyte size, there-
fore reflecting the situation in the EHD2 KO mouse (see also
ref. 53). We speculate that an imbalance in number, lifetime, and
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Fig. 7. Decreased EHD2 expression in obesity. (A) EHD2 expression level was analyzed in fat tissue of ob/ob or NZO mouse models compared to C57BL6/J mice
(n = 5). (B and C) Investigation of caveolae by EM [n(ob/ob mice) = 85/2; n(C57BL6/N) = 117/2]. Black arrowheads indicate caveolae. (D and E) EHD2 expression in
visceral (E) or subcutaneous WAT (F) in obese patients [n(normal) = 31; n(overweight) = 23; n(obesity grade 1) = 7; n(obesity grade 2) = 17; n(obesity grade 3) =
202]. (F) The model illustrates how FA uptake is affected by caveolae function. In the absence of caveolae, FA uptake is reduced, resulting in smaller LDs compared
to normal conditions. In the absence of EHD2, FA is increased, suggesting a regulatory function of EHD2 in caveolae-dependent lipid uptake. FFA, free fatty acid;
LD, lipid droplet. Box plots indicate median with whiskers from maximal to minimum value, or each replicate with mean ± SE is represented. Normal distributed
groups were analyzed by t test, and not normally distributed values with Mann–Whitney U test, *P < 0.05, **P < 0.001, ***P < 0.0001, ****P < 0.00001.
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mobility of caveolae may accompany the development and pro-
gression of obesity.
Methods
Please see SI Appendix, SI Materials andMethods for a detailed description of all
materials and methods. The datasets generated and analyzed during the current
study are available from the corresponding author on reasonable request.
EHD2 Delta E3 Mouse Strain Generation. The EHD2 targeting construct was
generated by insertion of two loxP sequences flanking exon 3 of EHD2 ge-
nomic DNA by homologous recombination in Escherichia coli as previously
described (54), including a pGK Neomycin and a diphtheria toxin A (DTA)
cassette. Electroporation of the linearized targeting vector in R1 embryonic
stem cells was performed. Mice carrying a loxP-flanked exon 3 of the EHD2
gene were mated to Cre deleter mice to generate EHD2 mutant (del/del)
mice. After backcrossing the EHD2 del/del mice with C57BL6/N (Charles River,
male) for six generations, only male EHD2 del/del or EHD2 del/+ mice were
used. All animals were handled according to governmental animal welfare
guidelines and were housed under standard conditions.
Human EHD2 Expression. All regulated procedures carried out on animals
involved in this publication were applied for and approved by the Landesamt
für Gesundheit und Soziales (LAGeSo, State of Berlin) and were in full
compliance with German and European Union animal protection laws. The
study was approved by the Ethics Committee of the University of Leipzig
(approval no. 159-12-21052012), and performed in accordance to the dec-
laration of Helsinki. All subjects gave written informed consent before
taking part in this study. Samples were treated as previously described (55).
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